3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
56
Precursor Cell Lymphoblastic Leukemia-Lymphoma
45
Myelodysplastic Syndromes
41
Leukemia, Lymphocytic, Chronic, B-Cell
30
Lymphoma, Non-Hodgkin
27
Multiple Myeloma
22
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
22
Hodgkin Disease
20
Leukemia
17
Myeloproliferative Disorders
16
Recurrence
15
Melanoma
15
Lymphoma, Follicular
15
Leukemia, Biphenotypic, Acute
15
Lymphoma, Mantle-Cell
14
Lymphoma
14
Leukemia, Myelomonocytic, Chronic
14
Lymphoma, Large B-Cell, Diffuse
13
Hematologic Neoplasms
13
Burkitt Lymphoma
11
Anemia, Refractory, with Excess of Blasts
11
Lymphoma, B-Cell, Marginal Zone
10
Lymphoma, B-Cell
10
Primary Myelofibrosis
8
Neoplasm, Residual
7
Neoplasm Metastasis
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Neuroblastoma
6
Neoplasms
6
Graft vs Host Disease
6
Interventions
peginterferon alfa-2b
1
liposomal doxorubicin
1
dolutegravir
1
brincidofovir
1
belinostat
1
Zidovudine
1
Tenofovir
1
Taxes
1
Paclitaxel
1
Lomustine
1
Irinotecan
1
Introns
1
Gemcitabine
1
Doxorubicin
1
Cyclophosphamide
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia-Lymphoma, Adult T-Cell
×
fludarabine phosphate
×
1 year
×
Clear all
No trials found.